Peer-influenced content. Sources you trust. No registration required. This is HCN.
MDLinx
First-line pulsed field catheter ablation outperformed antiarrhythmic drug therapy for rhythm control at one year in patients with persistent atrial fibrillation, with similar serious adverse event rates.
Cardiology May 19th 2026
Annals of Internal Medicine
“Catheter ablation reduced risks for ischemic stroke after 30 days (relative risk 0.63), mortality (RR 0.73), and heart failure hospitalization (RR 0.68), but increased ischemic stroke risk at or before 30 days (RR 6.81).”
Cardiology July 29th 2025
EP – Europace
In this 22-center study of repeat ablations following PFA, 45% of patients maintained complete pulmonary vein isolation from their initial procedure, with subsequent success rates varying significantly by arrhythmia type.
Cardiology February 10th 2025